Fig. 2From: RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signaturesPrincipal component analysis (PCA) of all samples based on the expression values of 19,574 protein-coding genes. A The first principal component (PC1) explaining 49.5% of the variance in the data separates cell lines from tissue samples. B PC3 explaining 6.3% of the variance in the data distinguishes between the specific patients. Dashed lines connect the cell line and original tissue of a given patient (“paired samples”)Back to article page